:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/JXTS56626RDADFEJ2F4BEHVRJU.jpg "Bivalent vaccine: people over 18 can now receive the new dose of protection against COVID -19 1")
To continue the process of vaccination against COVID-19, the Ministry of Health (Minsa) announced the start of the application of the bivalent dose for people aged 18 to 59as long as they have received the previous four doses of protection.
Back to school: masks, medical alcohol consumption and what will no longer be necessary to use for the return to school
The start of the 2023 school year is scheduled for March 13, but some private students started their lessons on March 1. Parents must take into account the recommendations of the authorities in the face of the COVID-19 pandemic.
“All people over the age of 18 are welcome to receive the bivalent vaccine, provided they have the fourth dose. We are pleased that over 500,000 people, including healthcare workers and adults over 60 years, already benefit from this dose of protection”, declared the Deputy Minister of Public Health, Maria Elena Aguilar del Aguila.
The condition for being able to receive this new dose of the vaccine against COVID-19 is to have the protection scheme of four monovalent doses and spent at least two months from the application of the last.
Since the first case of COVID-19 was detected in Peru in March 2020, there have been five waves of infections. The first two solas recorded in the same year were devastating, plunging the healthcare sector into crisis and reporting thousands of hospitalizations and deaths.
Leukemia, the most common type of cancer among miners in Peru
According to the Medical College of Peru, there are only 37 pediatric oncologists to care for all infants in the country. GlobeLiveMedia spoke with the specialist Ana María Gloria Paredes, who gave more details about this pathology.
From the start of vaccination in 2021, subsequent waves of infections did not experience the peaks recorded in 2020, thanks to the protection offered by vaccines. Currently, the Omicron variant and its subvariants are the most dominant in the world and the bivalent vaccine provides protection against the parent virus and the omicron BA.4 and BA.5 variants.
The vaccination process with the bivalent dose It started with health personnel and was later extended to people over 60 and people with a risk factor, who must have applied at least three bivalent doses before.
Minsa announces that the use of medical and therapeutic cannabis is already regulated
The regulation stipulates that associations of patients who use cannabis can apply for a license for artisanal production.
The ace pregnant women can receive the bivalent booster dose after completing 12 weeks of pregnancy, and at least two months have passed since the fourth dose. During this time, the cancer patients They will be able to go to the vaccination centers three months after receiving the fourth dose, provided they have completed their cancer treatment and on the prior recommendation of their doctor.
Meanwhile, according to the vaccination plan against COVID-19 organized by the Minsa, minors between 5 and 11 years old they can receive the third dose after three months of application of the second. The population of 12 to 17 years old The third dose can also be applied three months after the administration of the second. For people over the age of 18 and 59 years old they can receive the fourth dose five months after receiving the third.
It should be noted that minors between 6 months and 5 years receive two doses of the pediatric COVID-19 vaccine with an interval of 28 days between each application.
According to the data provided on the platform Single National Health Information Repository (Reunis) of the Minsa, here is how the vaccination process takes place at the general level:
First dose: 94%
Second dose: 90.31%
Third dose: 74.25%
Fourth dose: 26.40%
Bivalent dosage: 7.71%
